
Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …

GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …

UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …

Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over …

Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its …

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …

MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US. Across the total number, …

AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …

MSD is due to cut 148 jobs at its North Wales, Pennsylvania campus effective September 12, according to the company’s …

Swiss pharmaceutical company Roche (VTX: ROG) has confirmed that 240 jobs are to go at their Irish site in Clare, …

Clovis Oncology (NASDAQ: CLVS) is set to cut up to 35% of its workforce following the US Food and Drug …

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …

GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …